- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07460973
Nen ŨnkUmbi/EdaHiYedo Plus (We Are Here Now Plus): a Multi-level Intervention to Reduce Health Disparities Among American Indian Youth (NE+)
Nen ŨnkUmbi/EdaHiYedo Plus (NE+): a Multi-level Intervention to Reduce Health Disparities Among American Indian Youth
We Are Here Now - Plus (NE+) is a holistic, culturally centered, and multilevel intervention for American Indian youth to improve sexual health, mental health, and substance use outcomes. The goal of this intervention is to learn if NE+ can decrease substance use during sex, decrease sexual activity, increase condom use, increase positive mental health, increase caregiver(parent)-youth communication, increase communication between school personnel and youth, and increase utilization of clinical services. Researchers will compare one intervention arm to one control arm to see if the aforementioned indicators improve among the intervention arm for youth participants.
Youth participants (ages 12-18) will participate in a 9-month educational program consisting of 18 modules that discuss healthy relationships, puberty & physiology (separate girls & boys), parenting, pregnancy and sexually transmitted infections (STIs) and Human Immunodeficiency Virus (HIV) prevention, sexual avoidant behaviors with a focus on abstinence, substance use prevention with a focus on abstinence and refusal skills, & positive mental health, resources; skills (high school)- self-efficacy, refusal skills, decision making, communication, abstinence; skills (middle school) - health knowledge, self-efficacy, boundaries, communication, abstinence. Youth will also participate in six teachings offered by local cultural leaders that coincide with educational modules, including: kinship networks & family; cultural values; 7 sacred roles of tribal members; ceremonies; cultural teachings and responsibilities of women & men in tribe & ceremonies; Indigenous worldview; skills - knowledge of traditional ways, language & cultural people to go to for help; community members roles & responsibilities in tribe & ceremonies.
Caregiver (parent) participants will participate in three in-person visits/meetings to discuss the following: visit 1 - age specific physical, cognitive, emotional, spiritual development; visit 2: prevention of substance use, promoting positive mental health, promotion of healthy relationships; skills -communication with youth; visit 3 - pregnancy and STIs/HIV prevention and abstinence from sex, parental monitoring, tribal resources.
School personnel participants will participate in three workshops during teacher in-service training days, including the following information: Workshop 1 - cultural teachings on kinship & family networks, cultural values, cultural age & community roles; Workshop 2 - sexual risk avoidant behaviors, substance use prevention, positive mental health promotion, pregnancy STIs/HIV prevention, tribal resources; Workshop 3 - culturally respectful communication skills by age & youth (boy/girl) and age & caregiver (male/female); skills - knowledge of cultural ways, substance use prevention, positive mental health promotion, sexual risk avoidant behaviors, culturally respectful communication.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Elizabeth L Rink, PhD, MSW
- Phone Number: 406-600-0297
- Email: elizabeth.rink@montana.edu
Study Contact Backup
- Name: Molly Secor, PhD
- Email: molly.secor@montana.edu
Study Locations
-
-
Montana
-
Bozeman, Montana, United States, 59715
- Recruiting
- Fort Peck Community College
-
Contact:
- Olivia Johnson, MA
- Phone Number: 406-786-7427
- Email: ojohnson@fpcc.edu
-
Contact:
- Ashley Solheim-Azure, AA
- Phone Number: (406)480-9389
- Email: aazure@fpcc.edu
-
Principal Investigator:
- Robyn Baker, MA
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 12 to 18 years old
- Registered member of a federally recognized tribe or an associate tribal member
- Resident of the Fort Peck Reservation with a caregiver who agrees for their child to participate in the intervention
Exclusion Criteria:
- Not meeting any of the aforementioned inclusion criteria
- Having a medically identified physical or cognitive impairment that would impede their understanding of and participation in the educational content, activities, and teachings of the intervention
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Control
|
Participants will not receive any educational material in this arm and will only provide survey responses to act as control observations.
|
|
Experimental: NE+ intervention
|
School-based learning intervention consisting of 18 learning modules taught over 9 months.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline in mean condom use frequency relative to sexual intercourse frequency in the past month
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean number of participants reporting if they have ever had sexual intercourse
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
Measuring the mean number of youth who report having ever had sex to examine if youth in the intervention arm have less initiation of sexual intercourse compared to youth in control arm.
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
Change from baseline in mean age when participants first engage in sexual intercourse
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean number of lifetime sex partners
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean number of recent (past-month) sex partners
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean number of times participants recently (in the past month) engaged in sexual intercourse
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean number of times birth control was used during sexual intercourse
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean depressive symptoms score
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change in baseline in mean number of youth who have ever smoked a cigarette
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean anxiety score
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean age of youth initiating tobacco use
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean number of days (of past 30 days) youth reported smoking cigarettes
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean number of youth who reported ever using an electronic vapor product
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean number of times injection drugs were used in past 30 days
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean number of times injection drugs were used in lifetime
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean number of times hallucinogenic drugs were used in past 30 days
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean number of times ecstasy was used in past 30 days
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean number of times methamphetamines were used in past 30 days
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean number of times heroin was used in past 30 days
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean number of times glue, aerosol spray, or other inhalants were used in past 30 days
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean number of times cocaine was used in past 30 days
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean number of times hallucinogenic drugs (e.g., acid) were used in lifetime
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean number of times ecstasy was used in lifetime
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean number of times methamphetamines were used in lifetime
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean number of times heroin was used in lifetime
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean number of times glue, aerosol spray, or other inhalants were used in lifetime
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean number of times any form of cocaine has been used in lifetime
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean number of times prescription pain medicine without doctor's prescription was used in the past 30 days
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean number of times prescription pain medicine was used without a doctor's prescription in lifetime
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean number of times in the past 30 days youth reported using marijuana
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean age at which youth reported first using marijuana for the first time
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean number of times youth reported using marijuana in their life
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean number of drinks (in the past 30 days) that youth reported having in a row
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean number of days (in past 30 days) youth reported having 4 or more drinks of alcohol in a row (for males) or 5 or more drinks of alcohol in a row (for females)
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean number of days (in past 30 days) youth reported having at least one drink of alcohol
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in the mean age at which youth reported having alcohol for the first time
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean number of days (in past 30 days) youth reported using an electronic vapor product
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline in mean condom use self-efficacy score derived from Talashek's Condom Use Self Efficacy Scale
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
Talashek's condom use self-efficacy scale consists of 6 questions regarding condom use self-efficacy (e.g., "I could get condoms") with likert-type responses ranging from 1-5 (1 Yes, I could; 2 Maybe I could; 3 Don't Know; 4 Probably I could not; 5 No, I could not).
Scores from each item will be summed to create a sum score between 5 and 30.
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
Change from baseline in mean condom use intention score derived from one question with a likert-type response set from the Youth Health Risk Behavioral Inventory
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
One single question asks youth how likely it is that they intend to use a condom the next time they have sex, assessed by a likert-type response set of answers ranging from 1-5, where 1 is the least likely and 5 is the most likely.
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
Change from baseline in mean beliefs about birth control score from the pathways of choice survey
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
18 questions from the pathways of choice survey, each with a likert-type response set (1 = strongly disagree, 2 = disagree, 3 = neither agree nor disagree, 4 = agree, 5 = strongly agree) will be summed to create a composite score between 18 and 90.
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
Change from baseline in mean score of knowledge of healthy relationships from the Native STAND (students together against negative decisions) survey
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
10 questions from the Native STAND survey ask participants if a certain characteristic is representative of a healthy relationship.
Participants respond "no" or "yes", where answers of "no" are coded to 0 and "yes" coded to 1.
All answers will be summed to create a composite score from 0 to 10.
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
Change from baseline in mean sexual refusal score derived from a sexual refusal scale from the sexual refusal skills regarding sex
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
Participants are asked 7 questions pertaining to their confidence in being able to refuse sex in different scenarios.
The responses range from 1-5 (1, I Definitely Can Say No; 2, I Can Say No; 3, I Don't Know; 4, I Can't Say No; 5, I Definitely Can't Say No).
All responses will be summed to create a composite score ranging from 7 to 35.
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
Change from baseline in mean score on knowledge of sexually transmitted infections and other sexual health items
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
|
Change from baseline in mean caregiver-youth communication score derived from the Parent-Adolescent Communication Scale
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
Participants are asked 5 questions about how often they speak with their parents about topics regarding sexual health (e.g., "In the past 6 months, how often have you and y our parent(s) talked about how to use condoms?"),
where responses range from 0=never, 1=rarely, 2=sometimes, and 3=often.
Responses are summed to create a composite score ranging from 0 to 15.
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
Change from baseline in mean caregiver-adolescent openness score derived from the Parent-adolescent communication scale
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
Participants are asked 10 questions regarding their openness with their parents (e.g., "I can discuss my beliefs with my mother/father without feeling restrained or embarrassed"), where responses are: 1, Strongly disagree; 2, Somewhat disagree; 3, Neither disagree nor agree; 4, Somewhat agree; 5, Strongly agree.
Responses will be summed to create a composite score ranging from 10 to 50.
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
Change from baseline in mean cultural connectedness score derive from the cultural connectedness scale (short form)
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
Participants are asked 10 questions regarding how connected they feel to their culture in three different domains (identity, spirituality, and traditions).
Response sets include 1=yes and 0=no, as well as likert-type responses (1=strongly disagree, 2=somewhat disagree, 3=neither agree nor disagree, 4=somewhat agree, 5=strongly agree).
Responses will be summed to create a composite score for cultural connectedness ranging from 0 to 30.
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
|
Change from baseline in mean communication score between youth and school personnel derived from an adapted Ambulatory Care Experiences (ACE) survey.
Time Frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
Participants are asked 8 questions about their communication and relationship with school personnel, with response sets from 1, Strongly disagree; 2, Somewhat disagree; 3, Neither disagree nor agree; 4, Somewhat agree; 5, Strongly agree.
Responses will be summed to create a composite score from 8 to 40.
|
From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Elizabeth L Rink, PhD, MSW, Montana State University
- Principal Investigator: Julie Baldwin, PhD, Northern Arizona University
- Principal Investigator: Molly Secor, PhD, Montana State University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R01MD012761-07 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
University of Vermont Medical CenterAvocado Nutrition CenterRecruitingHealthy | Healthy Volunteers | Healthy Subjects | Healthy Volunteer | Healthy Adult | Healthy Volunteers Only | Healthy Male and Female Subjects | Healthy Non-smokersUnited States
-
Dragonfly TherapeuticsRecruitingHealthy | Healthy Participants | Healthy Adult Females | Volunteer | Healthy Adult MaleAustralia
-
University of PalermoCompletedHealthy | Healthy Volunteers | Healthy Subjects | Healthy Participants | Static Stretching | Stretch | StretchingItaly
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Umm Al-Qura UniversityActive, not recruitingHealthy | Healthy Participants | Healthy Adult | Healthy Women | Healthy Adult Females | Healthy Adult Participants | Healthy Young Adults | Healthy Adult Female Participants | Healthy Adult Male | Poor Sleep Quality | Healthy (Controls) | Poor Sleeping Quality | Healthy Adult Male Subjects | Health Adult SubjectsSaudi Arabia
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
University of PalermoCompletedHealthy Participants | Healthy Adult Participants | Healthy Young AdultsItaly
-
PfizerNot yet recruitingHealthy | Healthy AdultsUnited States
-
RAGE BioRecruitingHealthy | Healthy SmokerAustralia
Clinical Trials on NE+
-
SEAMEO Regional Centre for Food and NutritionIndonesia University; Ministry of Health Republic of Indonesia; Health Polytechnic... and other collaboratorsUnknownAnemia | Stunting | Complementary Feeding Recommendation | Linear Programming | Indonesia | Infant and Young Children | Problem NutrientsIndonesia
-
University of VermontRecruiting
-
Hutom CorpSamsung Medical Center; Asan Medical Center; Chonnam National University Hospital and other collaboratorsRecruiting
-
Hutom CorpAsan Medical CenterEnrolling by invitationNephrectomy | Renal Mass | Robot-assisted Urological Surgery | Kidney Neoplasm | Surgical Navigation SystemsSouth Korea
-
Central Hospital, Nancy, FranceCompletedHantavirus Nephropathy | Hantavirus InfectionFrance
-
China Medical University HospitalRecruiting
-
University of ValenciaHospital de la RiberaUnknown
-
University of PennsylvaniaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Medline IndustriesF2 LabsCompletedAdhesion of the Neutral Electrode 21padUnited States
-
University of VermontCompletedFood SecurityUnited States